LACK OF INHIBITORY ACTION OF AFLATOXIN ON THE INDUCTION OF DRUG-METABOLIZING ACTIVITIES OF LIVER MICROSOMES BY PHENOBARBITAL

LACK OF INHIBITORY ACTION OF AFLATOXIN ON THE INDUCTION OF DRUG-METABOLIZING ACTIVITIES OF LIVER MICROSOMES BY PHENOBARBITAL

LACK OF INHIBITORY INDUCTION OF OF LIVER RYUICHI ACTION MICROSOMES KATO, OF AFLATOXIN DRUG-METABOLIZING AKIRA BY THE PHENOBARBITAL TA...

152KB Sizes 0 Downloads 20 Views

LACK

OF

INHIBITORY

INDUCTION OF

OF

LIVER

RYUICHI

ACTION

MICROSOMES

KATO,

OF

AFLATOXIN

DRUG-METABOLIZING

AKIRA

BY

THE

PHENOBARBITAL

TAKANAKA,

AND YOSHIHITO

ON

ACTIVITIES

KINICHI

ONODA

OMORI

Department of Pharmacology, National Institute of Hygienic Sciences,Setagaya-ku, Tokyo Received for publication

April 5, 1969

Aflatoxin is a mycotoxin and has been known as a potent hepatotoxic and carcinogenic compound (1, 2). It has been recently established that aflatoxin primarily inhibits DNA-dependent

RNA polymerase of liver

nuclei, but not primarily inhibits protein synthesis (3, 4). Recently, Wogan and Friedman have reported that aflatoxin inhibits the induction of tryptophan pyrrolase by cortisone, but does not inhibit that by tryptophan

(5).

These results suggest that aflatoxin interferes the

formation of new messenger RNA, but does not interfere the biosynthesis of the new enzyme protein (3, 5). The administration of phenobarbital somes (6).

markedly increased the drug-metabolizing activities of liver micro

The de novoenzyme protein synthesis is assumed to be involved in the phenobarbital-induced

increase in the drug-metabolizing

activities, but the detail mechanism of the induction is not yet elucidated

(6). In the present communication, the preliminary results on the effect of aflatoxin on th° induction of drug-metabolizing activities by phenobarbital are described. Male rats of Wistar strain, weighing about 90 g were used. solved in distilled water and given intraperitoneally

Phenobarbital sodium (80 mg/kg) was dis

40 hours before the experiments.

Aflatoxin B1* (3

mg/kg) was dissolved in dimethylsulfoxide (3 mg/ml) and given intraperitoneally 2 hours before phenobar bital pretreatment. The rats were sacrificed by decapitation and the liver was immediately removed and homogenized with 3 volumes of 1.15°,/° KC1 in a Teflon-glass homogenizer. at 10,000 x g for 20 minutes.

The homogemte was centrifuged

The preparation of the incubation mixture and the determinations of amino

pyrine N-demethylation and pentobarbital oxidation were essentially same as described in a previous paper (7). Pentobarbital

anesthesia was determined

by the duration of the loss of righting reflex.

As shown in Table 1, the induction of aminopyrine N-demethylating and pentobarbital oxidating activities by phenobarbital

was not prevented by aflatoxin at all.

加 藤   隆一 ・高 仲   正 ・小 野 田  欽 一 ・大 森   義 仁 ~`

Vurihed Hygienic

atlatoxin Sciences.

lil was

kindly

supplied

from

Drs . M.

Icurata

and

-ti.

1 anabe,

ivational

Institute

or

TABLE 1.

Effect

and

of

aflatoxin

pentobarbital

on

the

oxidation

induction by

of

aminopyrine

N-demethylation

phenobarbital.

Rats were intraperitoneally pretreated with phenobarbital (60 mg/kg) 40 hours before sacrifice. Aflatoxin (3 mg/kg) was given intraperitoneally 2 hours before phenobarbital pretreatment. The figures in parentheses indicate number of rats used. The results are exoressed as averave+S.E. TABLE 2.

Effect

barbital

of

aflatoxin

on

the

phenobarbital-induced

shortening

of

pento

anesthesia.

Rats were intraperitoneally pretreated with phenobarbital (60 mg/kg) 40 hours before pentobarbital administration (35 mg/kg, i.p.). Aflatoxin (3 mg/kg) was given intraperitoneally 2 hours before phenobarbital. Similarly, the decrease in pentobarbital aflatoxin (Table 2).

anesthesia by phenobarbital

treatment was not prevented by

Moreover, these results indicate that the induction of drug-metabolizing

activity by

phenobarbital may be enhanced by aflatoxin. Three mg/kg of aflatoxin is toxic in immature rats (1) and according to Wogan and Friedman this dose of aflatoxin inhibits the induction of tryptophan

pyrrolase at least for 7 days (5).

The inhibition by the inhibitors of protein synthesis on the induction of drug-metabolizing activities is well established (6, 8).

Although

the inhibition of the induction

by actinomycin D has been reported

(8), these results are assumed to be doubtful for its high toxicity (9). The results of present study, therefore, suggested that the biosynthesis of the new messenger RNA does not play an important role in the induction of drug-metabolizing

activities by phenobarbital.

According to Garren et al. actinomycin D, when given after the administration of cortisone, enhances the induction of tryptophan pyrrolase through the inhibition in formation of the repressor (10). Although these results are not fully reproduced by other investigator, therefore, the possible action of aflatoxin on

the formation of repressor for the biosynthesis of drug-metabolizing

enzymes could not be excluded.

On the other hand, Gurtoo et al. (11) have recently reported that the treatment with aflatoxin modified the apparent Michaelis constant (Km) for benzpyrien hydroxylase. the inductive effect of phenobarbital aminopyrine N-demethylation

Since the alteration of Km may nullify

in the present investigation, a possible alteration of apparent Km for

and pentobarbital

oxidation by aflatoxin should be investigated.

Further studies on the both possibilities are now under investigation for elucidating the mechanism of the induction of drug-metabolizing activities of liver microsomes by phenobarbital

and will be published in detail

in elsewhere. REFERENCES 1) WOGAN,G.N.: Bacteriol. Rev. 30, 460 (1966); 2)

BARNES,J.M. ANDBUTLER,W.H.: Nature, Lond. 202,

1016 (1964) ; 3) CLIFFORD,J.1. ANDREES, K.R.: Biochem.J. 102, 65 (1967) ; 4) CLIFFORD,J.I., REES, K.R. ANDSTEVENS,M.E.M.: Biochem.J. 103, 258 (1967) ; 5) WOGAN,G.N. ANDFRIEDMAN,M.A.: Archs Biochem.Biophys.128, 509 (1968) ;

6)

CONNEY,A.H.: Pharmac. Rev. 19, 317 (1967) ;

T. ANDTOMIZAWA, S.: Jap. J. Pharmac. 18,356 (1968) ; R.: unpublished observation;

10)

8)

7)

KATO,R., OSHIMA,

KATO, R.: Med. exp. 3, 95 (1960) ; 9)

KATO,

GARREN,L.D., HOWELL, R.R., TOMKINS,G.M. AND CRocco, R.M.:

Proc. nat. Acad. Sci., Wash. 52,1121 (1964) ;

11) GURTOO,H.L., CHAMPBELL, T.C., WEBB,R.E. ANDPLOW

MAN,K.M.: Biochem. Biophys. Res. Comm. 31, 588 (1968)